OUR EXPERIENCE WITH TERIPARATIDE (FORSTEO) IN PATIENTS WITH SEVERE OSTEOPOROSIS

被引：0
|
作者：
Popova, V. P. [1 ]
Popova, M. P. Gebeva [1 ]
Vazhev, Z. V. [2 ]
Ronchev, Y. R. [3 ]
Kraev, K. K. [1 ]
Batalov, A. B. [1 ]
机构：
[1] Med Univ Plovdiv, Med Fac, Dept Rheumatol, Plovdiv, Bulgaria
[2] Med Univ Plovdiv, Med Fac, Dept Cardiac Surg, Plovdiv, Bulgaria
[3] Med Univ Plovdiv, Med Fac, Dept Inubil, Plovdiv, Bulgaria
来源：
OSTEOPOROSIS INTERNATIONAL | 2021年 / 32卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P399
引用
收藏
页码：S231 / S232
页数：2
相关论文
共 50 条
  • [31] Effectiveness of Teriparatide in Women Over 75 Years of Age with Severe Osteoporosis: 36-Month Results from the European Forsteo Observational Study (EFOS)
    J. Bernard Walsh
    Willem F. Lems
    Dimitrios Karras
    Bente L. Langdahl
    Osten Ljunggren
    Astrid Fahrleitner-Pammer
    Annabel Barrett
    Gerald Rajzbaum
    Franz Jakob
    Fernando Marin
    Calcified Tissue International, 2012, 90 : 373 - 383
  • [32] Prescribing teriparatide (PTH, FORSTEO) and NICE guidelines
    Ali, H. A.
    Hassan, H. O.
    Al-Allaf, A. W. A.
    Allen, T.
    RHEUMATOLOGY, 2006, 45 : I177 - I177
  • [33] Clinical experience with teriparatide for the treatment of osteoporosis.
    Bachrach, L.
    Camacho, P. M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S296 - S296
  • [34] Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy
    Nasomyont, N.
    Keefe, C.
    Tian, C.
    Hornung, L.
    Khoury, J.
    Tilden, J.
    Hochwalt, P.
    Jackson, E.
    Rybalsky, I.
    Wong, B.
    Rutter, M.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S132 - S132
  • [35] Persistence with teriparatide in men with osteoporosis: The UK experience
    Abhishek, Abhishek
    Pande, Ira
    RHEUMATOLOGY, 2008, 47 : II173 - II173
  • [36] Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy
    Nasomyont, N.
    Keefe, C.
    Tian, C.
    Hornung, L.
    Khoury, J.
    Tilden, J. C.
    Hochwalt, P.
    Jackson, E.
    Rybalsky, I
    Wong, B. L.
    Rutter, Meilan M.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (12) : 2449 - 2459
  • [37] The impact of switching once-weekly teriparatide to denosumab in severe osteoporosis patients
    Miyagi, Masayuki
    Murata, Kosuke
    Koyama, Tomohisa
    Fujimaki, Hisako
    Naruse, Koji
    Inoue, Gen
    Takaso, Masashi
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 175 - 175
  • [38] Pain reduction after treatment with teriparatide in 33 patients affected by severe osteoporosis
    Massafra, U.
    Martin, L. S.
    Ragno, A.
    Migliore, A.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S86 - S86
  • [39] Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy
    N. Nasomyont
    C. Keefe
    C. Tian
    L. Hornung
    J. Khoury
    J. C. Tilden
    P. Hochwalt
    E. Jackson
    I. Rybalsky
    B. L. Wong
    M. M. Rutter
    Osteoporosis International, 2020, 31 : 2449 - 2459
  • [40] Persistence with teriparatide in patients with severe osteoporosis: Preliminary data from Northern Italy
    Massarotti, M.
    Gandolini, G.
    Bevilacqua, M.
    Longhi, M.
    Pietrogrande, L.
    Santi, I.
    BONE, 2009, 44 (02) : S436 - S437
12345